Astellas sales and marketing update

Astellas' Astellas Pharma Europe Ltd. launched Betmiga mirabegron in the U.K. to treat overactive bladder (OAB). The price of the adrenergic receptor beta 3 (ADRB3) agonist is £29 ($43.92) for a pac...